According to the agency Astra Press, the laboratory AstraZeneca announced a new delay in the delivery of its vaccine dose against Kovid-19 in the European Union (EU) on Saturday (13). The company claimed production problems and export restrictions.
A spokeswoman for AstraZeneca said the group decided to move towards its production centers outside the European Union, but “unfortunately, export restrictions will reduce distribution in the first quarter” and “probably”.
Laboratory vaccines began to be distributed in the European Union in February. The goal was to deliver 100 million doses in the first half of 2021 (30 million in the first quarter, 70 million in the second).
The European Commission, which negotiated the contract on behalf of its 27 member states, was criticized for slow delivery in Europe and the delay of the AstraZeneca Group. Now, delivery is expected to pick up in the second quarter.
The European Commission plans to immunize 70% of Europeans before the end of the northern summer in August, although announcements for late delivery of doses could throw a bucket of cold water at the prospect.
VIDEO: Approved definitive registration of Oxford vaccine in Brazil
No definite registration Brazil
Not to brazil National Health Monitoring Agency (Anvisa), this Friday (12), definitive registration for the AstraZeneca / Oxford vaccineWith the manufacturing phase in Brazil.
“For the vaccine, two separate registrations were provided: one in the name of AstraZeneca, the other in FiroCruz. The two companies could, therefore, adopt different strategies of product distribution and commercialization”, informed the agency.
